For Hypothyroidism

Weight loss support when your thyroid is in the picture.

Physician-reviewed care that respects your thyroid history

Hypothyroidism is real and it makes weight loss harder when undertreated. Get the thyroid right first. Then a Puri-affiliated physician can evaluate whether compounded semaglutide or tirzepatide may fit your care plan. GLP-1 medications carry specific thyroid-related warnings that a real provider conversation will cover.

Hypothyroidism and GLP-1: read this first.

Quick summary

Hypothyroidism and GLP-1: read this first.

If you are short on time, here is the TL;DR. Hypothyroidism affects roughly 5 percent of US adults and is more common in women. Untreated hypothyroidism slows metabolism and makes weight loss feel impossible. The first step is always proper thyroid management with a knowledgeable provider, including a full thyroid panel (TSH, free T4, free T3, antibodies).

GLP-1 medications carry specific warnings related to medullary thyroid carcinoma. Patients with personal or family history of MTC or MEN2 should not take GLP-1. For most patients with stable, treated hypothyroidism, GLP-1 may still be an option after a real provider conversation. Compounded versions are not FDA-approved.

~5%
US adults
Diagnosed cases
5x
More common
In women
TSH+
Full panel
Beyond just TSH

The Complete Guide

Hypothyroidism and weight loss: get the thyroid right first

A research-grounded guide for adults with hypothyroidism who want to understand their options, get proper thyroid care, and decide whether GLP-1 medication may fit into their plan.

Reviewed by Puri's care team12 minute read

What hypothyroidism actually is

The thyroid is a small gland in the front of the neck. It produces hormones (T4 and T3) that regulate how fast your body uses energy. Hypothyroidism is what happens when the thyroid does not produce enough of these hormones. The most common cause in the US is Hashimoto's, an autoimmune condition where the body's immune system attacks the thyroid over years.

Roughly 5 percent of US adults have hypothyroidism. Many cases are subclinical, meaning thyroid hormone levels are still in the lab-normal range but elevated TSH (thyroid stimulating hormone) suggests the thyroid is straining to keep up. Women are affected at higher rates than men.

The most important thing to know: properly treated hypothyroidism does not necessarily prevent weight loss. Untreated or undertreated hypothyroidism can make it dramatically harder. Get your thyroid status right first.

How thyroid hormones affect weight

Thyroid hormones set the pace of cellular metabolism. When levels are low, the body slows down. Resting metabolic rate decreases. Energy drops. Cold intolerance shows up. Hair thins. Bowel movements slow. And weight tends to creep up, even when eating habits have not changed.

The weight gain from hypothyroidism is real, but it is usually modest in well-managed cases. The bigger issue is often that subclinical or undertreated hypothyroidism quietly makes every other lifestyle change harder. If your TSH is high or your free T3 is low, no diet plan is going to work the way it should.

What proper thyroid testing looks like

Many primary care visits only check TSH. That misses a lot. A complete thyroid evaluation usually includes:

  • TSH. The pituitary signal that tells the thyroid to make more hormone. High TSH usually means the thyroid is struggling.
  • Free T4. The main thyroid hormone produced by the gland.
  • Free T3. The active hormone the body actually uses. T4 is converted to T3 in tissues.
  • Reverse T3. An inactive form. Useful for understanding conversion patterns in some patients.
  • TPO and TG antibodies. Help identify Hashimoto's even when other levels look normal.

If you have not had a full panel run, it is worth asking. The standard 'TSH only' check is fast and cheap, but it misses subclinical cases and conversion problems that often explain stubborn weight issues.

Get your thyroid right before changing anything else

GLP-1 medications can be a useful tool for weight loss. They are not a substitute for proper thyroid treatment. If your hypothyroidism is undertreated, no GLP-1 will compensate fully. The metabolic baseline is too low for any weight loss approach to work efficiently.

Standard treatment for hypothyroidism is levothyroxine, a synthetic form of T4. Some patients also benefit from a T3 component or a combination product. Dosing is highly individual and based on labs and symptoms together. Your endocrinologist or primary care provider should manage this. A telehealth weight loss platform is not the right place to dose thyroid medication.

Where GLP-1 fits for hypothyroid patients

Once your thyroid is well-managed, weight loss is still possible. Many patients with treated hypothyroidism reach a metabolic state where standard interventions work again. For some, additional support from a GLP-1 medication may be appropriate.

GLP-1 receptor agonists do not affect thyroid hormone production directly. They act on appetite, gastric emptying, and insulin signaling. For a hypothyroid patient with controlled labs and a BMI that meets clinical criteria, a Puri-affiliated provider may discuss whether compounded semaglutide or tirzepatide is appropriate.

There is one important consideration. GLP-1 medications carry warnings related to medullary thyroid carcinoma and MEN2 in their prescribing information. Patients with a personal or family history of these conditions should not take GLP-1 medications. A licensed provider will screen for this during intake.

What the research shows

Most large GLP-1 weight loss trials enrolled adults with obesity or overweight plus a related health condition. Hypothyroidism is common in these populations, so many trial participants were managing it as well. A few notes from the literature:

  • Brand-name semaglutide (Wegovy). Trials reported average weight reductions of roughly 15 to 17 percent over 68 weeks in trial participants who completed the study.
  • Brand-name tirzepatide (Zepbound). Trials reported average weight reductions of up to 22.5 percent at the highest dose over 72 weeks.
  • Subgroup data on thyroid status. Specific subgroup analyses of thyroid patients are limited in the published literature. Patients with stable, treated hypothyroidism are generally not excluded from trials.
  • Thyroid safety signals. GLP-1 medications carry boxed warnings related to medullary thyroid carcinoma based on rodent studies. Human relevance is uncertain but the warning remains in prescribing information.

These findings describe brand-name FDA-approved products. Compounded versions have not been studied the same way.

A real plan when your thyroid is in the picture

Get the labs right first

Full thyroid panel. Address any deficiencies in iron, ferritin, vitamin D, B12, or selenium that affect thyroid conversion. If you have Hashimoto's, talk to your provider about whether dietary or other interventions might help calm the autoimmune component.

Build muscle to raise the metabolic floor

Strength training is one of the most effective ways to compensate for a slower thyroid baseline. More muscle means a higher resting metabolic rate, more glucose absorption, and a body that responds better to nutrition and movement.

Eat for energy and steady glucose

Adequate protein, fiber, and whole foods. Avoid extreme caloric restriction, which can suppress thyroid function further. Adequate carbohydrate intake matters more for hypothyroid patients than many crash diets recognize.

Sleep and stress

Both sleep and chronic stress affect thyroid conversion. Cortisol can shift the body toward more reverse T3, which is inactive. Managing stress and sleep is part of thyroid care, not separate from it.

Coordinate with your thyroid provider

If you start any new weight loss intervention, tell the provider who manages your thyroid. Significant weight loss can change thyroid medication needs over time. Routine monitoring should adjust as your body composition changes.

Who is NOT a candidate for GLP-1

  • Personal or family history of medullary thyroid carcinoma or MEN2 (these are direct contraindications for GLP-1).
  • Personal history of pancreatitis.
  • Pregnancy or breastfeeding.
  • Active or recent cancer.
  • Severe gastroparesis.
  • Active eating disorder.
  • Untreated or significantly undertreated hypothyroidism (treat the thyroid first).

How to think about the decision

  • Run the full thyroid panel first. Not just TSH.
  • Get your thyroid management dialed in. Work with an endocrinologist or knowledgeable primary care provider.
  • Build the lifestyle foundation. Strength, protein, sleep, and stress matter regardless of medication.
  • Then talk to a provider about GLP-1. Your full thyroid history will be reviewed during intake.

When you are ready, start your assessment.

Cited sources

Where the evidence comes from.

The research referenced throughout this guide draws from peer-reviewed clinical studies and guidelines published by medical professional societies. The studies describe findings for specific brand-name GLP-1 products. They do not represent promises of individual outcomes.

Where the evidence comes from.

The American Thyroid Association publishes clinical practice guidelines on the diagnosis and treatment of hypothyroidism in adults.

American Thyroid Association

The Endocrine Society publishes peer-reviewed clinical practice guidelines on thyroid disorders and their management.

Endocrine Society Clinical Guidelines

The National Institute of Diabetes and Digestive and Kidney Diseases provides educational information on hypothyroidism, Hashimoto's disease, and thyroid testing.

NIDDK: Hypothyroidism

Peer-reviewed clinical research has examined GLP-1 receptor agonists in adults with various endocrine conditions, including subgroup analyses of patients with thyroid disorders.

PubMed: GLP-1 thyroid

The US Food and Drug Administration publishes prescribing information for FDA-approved GLP-1 products, which includes thyroid-related boxed warnings.

FDA Drug Information

These links are provided for educational reference. Puri is not affiliated with these organizations. GLP-1 medications referenced may not be FDA-approved for the specific condition discussed. Compounded versions are not FDA-approved for any indication. Always talk to your healthcare provider before starting any new medication.

Programs

GLP-1 options available through Puri

Every plan includes a physician review, personalized dosing, provider messaging, and free shipping. A prescription is not guaranteed and requires licensed provider approval.

Most Popular

Compounded Semaglutide

$179/mo
  • Weekly self-injection
  • Compounded (not FDA-approved)
  • Personalized dosing
  • Provider oversight included
  • Free expedited shipping
Get Started

Compounded Tirzepatide

$249/mo
  • Weekly self-injection
  • Dual GLP-1 and GIP activity
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free expedited shipping
Get Started

Oral GLP-1 Tablets

$249/mo
  • No injections needed
  • Daily oral tablet
  • Compounded (not FDA-approved)
  • Provider oversight included
  • Free shipping
Get Started

Process

How it works

Three simple steps to start your journey

Get Approved
1

Get Approved

Complete a quick online evaluation to determine if treatment is right for you. No payment required upfront.

Get Prescribed
2

Get Prescribed

Once approved, a licensed provider will create a personalized treatment plan tailored to your needs and goals.

Receive Your Rx
3

Receive Your Rx

Your medication will be shipped directly to your door with free expedited delivery in discreet packaging.

FAQ

Common questions about hypothyroidism and GLP-1

Educational answers, not medical advice.

Satisfaction Guarantee

Care that puts you first.

Personalized support from licensed providers, with a satisfaction guarantee on your first month (terms apply). Individual results vary. Outcomes are not guaranteed.

Our Doctors

Medical care from
leading health experts

Our partnered physicians guide you every step of the way. Bringing expertise and genuine care to keep you supported.

Dr. Ana Lisa Carr

Dr. Ana Lisa Carr

Internal Medicine

St. George's University, School of Medicine

Dr. Kelly Tenbrink

Dr. Kelly Tenbrink

Emergency Medicine

American Board of Emergency Medicine